• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. SINGLE USE ASPIRATION NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. SINGLE USE ASPIRATION NEEDLE Back to Search Results
Model Number NA-201SX-4022
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemothorax (1896)
Event Type  Injury  
Manufacturer Narrative
The subject device was not returned to olympus medical systems corp. (omsc) for evaluation. Therefore, the exact cause of the reported event could not be conclusively determined. Since the lot number is unknown, the device history record could not be reviewed. However, omsc has only shipped devices that passed the inspection. In the literature, there was no description of the device's malfunction. On october 28th, the medical safety officer, who have the medical license, reviewed as bellow. The hemothorax might be serious injury because the patient was required additional hospitalization after ebus-tbna. In addition, it estimated that the patient was high risk because he had each cancer in the bronchus and the colon.
 
Event Description
On october 25, olympus medical systems corp. (omsc) received the literature "hemothorax after endobronchial ultrasound-guided transbronchial needle aspiration¿. The purpose of the literature was to report a case of hemothorax after endobronchial ultrasound-guided transbronchial needle aspiration (ebus-tbna) in a patient with a right upper lobe mass. The ebus-tbna was performed using a bronchoscope (bf-uc160f) and a needle (na-201sx-4022). In the literature, it was reported a case of hemothorax 24 hours after ebus-tbna as bellow. ¿twenty-four hours after the procedure the patient complained of increasing dyspnea and right-sided pleuritic chest pain. Hemoglobin fell to 49 g/l and a ct scan showed a high attenuation right-sided pleural effusion (fig. 2). A diagnostic thoracocentesis revealed a bloody pleural effusion with pleural fluid hematocrit >50% of the peripheral blood hematocrit (0. 18 vs. 0. 22) confirming that a hemothorax was present, and a chest tube was placed with complete recovery within 3 days. ¿ afterward, understanding a colonoscopy, he was diagnosed with advanced, stage iv lung adenocarcinoma, and synchronous sigmoid adenocarcinoma arising from tubulovillous adenoma. Chemotherapy was started and multiple transfusions were required due to anemia and thrombocytopenia secondary to hypersplenism. The outcome of the patient was death 2 months after diagnosis. On october 28th, the medical safety officer, who have the medical license, reviewed as bellow. The hemothorax might be serious injury because the patient was required additional hospitalization after ebus-tbna. In addition, it estimated that the patient was high risk because he had each cancer in the bronchus and the colon. Based on the available information, a direct relationship between the olympus product and these complications could not be determined. However, 1 case of a hemothorax might be serious injury. This is the report regarding 1 case of a hemothorax that may have required additional hospitalization.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSINGLE USE ASPIRATION NEEDLE
Type of DeviceSINGLE USE ASPIRATION NEEDLE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA 192-8507
Manufacturer Contact
kazutaka matsumoto
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8-507
JA   192-8507
426425177
MDR Report Key12768090
MDR Text Key280450280
Report Number8010047-2021-14245
Device Sequence Number1
Product Code FCG
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
K050503
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation
Type of Report Initial
Report Date 11/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/08/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberNA-201SX-4022
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received10/22/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unkown

Patient Treatment Data
Date Received: 11/08/2021 Patient Sequence Number: 1
-
-